Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia.

Autor: van Poelgeest EP; Centre for Human Drug Research, Zernikedreef 8, 2333, CL, Leiden, The Netherlands. Electronic address: evpoelgeest@chdr.nl., Dillingh MR; Centre for Human Drug Research, Zernikedreef 8, 2333, CL, Leiden, The Netherlands. Electronic address: mdillingh@chdr.nl., de Kam M; Centre for Human Drug Research, Zernikedreef 8, 2333, CL, Leiden, The Netherlands. Electronic address: mdekam@chdr.nl., Malone KE; Good Biomarker Sciences, Zernikedreef 8, 2333, CL, Leiden, The Netherlands. Electronic address: kmalon1@its.jnj.com., Kemper M; Academic Medical Center, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. Electronic address: e.m.kemper@amc.uva.nl., Stroes ESG; Academic Medical Center, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. Electronic address: e.s.stroes@amc.uva.nl., Burggraaf J; Centre for Human Drug Research, Zernikedreef 8, 2333, CL, Leiden, The Netherlands. Electronic address: kb@chdr.nl., Moerland M; Centre for Human Drug Research, Zernikedreef 8, 2333, CL, Leiden, The Netherlands. Electronic address: MMoerland@chdr.nl.
Jazyk: angličtina
Zdroj: Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2018 Jan - Feb; Vol. 89, pp. 39-46. Date of Electronic Publication: 2017 Oct 19.
DOI: 10.1016/j.vascn.2017.10.004
Abstrakt: Introduction: Although the effects of relatively high concentrations of endotoxin on endothelial activation/dysfunction and kidney markers has been described in literature, detailed insight in the LPS concentration-effect relationship, the magnitude, variability and timing of the response, and potential effects of endotoxemia on the kidneys is lacking. A study was performed to assess the effects of low- to moderate dose (0.5, 1 or 2ng/kg) endotoxemia on the endothelium and kidneys as measured by a panel of novel highly sensitive kidney injury markers.
Methods: This was a randomized, double-blind, placebo-controlled study with single ascending doses of LPS (0.5, 1 or 2ng/kg) administered to healthy male volunteers (3 cohorts of 8 subjects, LPS:placebo 6:2). Endothelial measures included selectins, cell adhesion molecules, and thrombomodulin. Renal measures included novel, sensitive and specific biomarkers of acute kidney injury.
Results: Endotoxin exposure resulted in consistent LPS dose-dependent responses in inflammatory markers, E- and P- Selectin, VCAM1, ICAM1, and thrombomodulin. The observed biological responses were transient, reaching a level of significance of at least <0.01 in the highest dose group and with an effect size which was dependent on the administered LPS dose. LPS-induced inflammatory and endothelial effects did not translate into a change in renal damage biomarkers, although at 2ng/kg LPS, subtle and transient biomarker changes were observed that may relate to (subclinical) tubular damage.
Discussion: We demonstrated that administration of a single LPS dose of 2ng/kg to healthy volunteers results in significant inflammatory and endothelial responses, without inducing clinically relevant signs of kidney injury. These findings support the application of the human endotoxemia model in future clinical pharmacology studies.
(Copyright © 2017 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: